Skip to content
Disclosery

Sarissa Capital Management LP

Follow

13F filer, CIK 1577524, GREENWICH, CT

Sarissa Capital Management LP reported $177,878,251 across 10 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000899140-26-000879

Period
2026-06-30
Reported value
$178M
Holdings
10
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
BHVNadded+19,128$285K
BIIBnew+950$205K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
INVAreduced-240,346-$5.46M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000899140-26-000879, largest first. % of portfolio is the value over $177,878,251, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INVAINNOVIVA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,277,000 shares; 2024Q4: 7,277,000 shares; 2025Q1: 2,816,022 shares; 2025Q2: 2,816,022 shares; 2025Q3: 2,816,022 shares; 2025Q4: 2,816,022 shares; 2026Q1: 2,130,950 shares; 2026Q2: 1,890,604 shares 1,890,604$42.9M24.14%-240,346Timeline
IRWDIRONWOOD PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 16,390,000 shares; 2024Q4: 16,390,000 shares; 2025Q1: 16,390,000 shares; 2025Q2: 15,919,435 shares; 2025Q3: 15,919,435 shares; 2025Q4: 15,919,435 shares; 2026Q1: 9,188,635 shares; 2026Q2: 9,188,635 shares 9,188,635$38.7M21.75%0Timeline
AMRNAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,242,527 shares; 2025Q3: 1,242,527 shares; 2025Q4: 1,673,395 shares; 2026Q1: 1,673,395 shares; 2026Q2: 1,673,395 shares 1,673,395$26.7M15%0Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 410,483 shares; 2024Q4: 309,116 shares; 2025Q1: 309,116 shares; 2025Q2: 303,151 shares; 2025Q3: 303,151 shares; 2025Q4: 303,151 shares; 2026Q1: 116,533 shares; 2026Q2: 116,533 shares 116,533$19.6M11.04%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,110,000 shares; 2024Q4: 833,799 shares; 2025Q1: 600,000 shares; 2025Q2: 588,357 shares; 2025Q3: 588,357 shares; 2025Q4: 396,357 shares; 2026Q1: 228,623 shares; 2026Q2: 228,623 shares 228,623$19.5M10.95%0Timeline
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 26,000 shares; 2024Q4: 63,000 shares; 2025Q1: 100,000 shares; 2025Q2: 96,251 shares; 2025Q3: 181,450 shares; 2025Q4: 181,450 shares; 2026Q1: 166,919 shares; 2026Q2: 166,919 shares 166,919$18.5M10.41%0Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 513,184 shares; 2026Q1: 563,184 shares; 2026Q2: 582,312 shares 582,312$8.66M4.87%+19,128Timeline
REGNREGENERON PHARMACEUTICALSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,190 shares; 2025Q4: 4,190 shares; 2026Q1: 4,190 shares; 2026Q2: 4,190 shares 4,190$2.61M1.47%0Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,399 shares; 2025Q4: 25,399 shares; 2026Q1: 25,399 shares; 2026Q2: 25,399 shares 25,399$468K0.26%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 26,950 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 950 shares 950$205K0.12%newTimeline

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000899140-26-000879 base2026-08-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000899140-26-000879 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0000899140-26-000574 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0000899140-26-000256 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0000899140-25-001320 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0000899140-25-000986 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0000899140-25-000705 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0000899140-25-000321 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0000899140-24-001252 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0000899140-24-000887 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000899140-24-000608 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0000899140-24-000250 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0000899140-23-001108 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0000899140-23-000886 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0000899140-23-000651 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0000899140-23-000407 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001567619-22-020094 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001567619-22-016259 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001567619-22-011017 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001567619-22-004425 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001567619-21-020494 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001567619-21-015920 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001567619-21-010558 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001567619-21-003998 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001567619-20-019849 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001567619-20-015463 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001567619-20-010481 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001567619-20-003999 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001567619-19-021592 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001567619-19-017020 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001567619-19-011163 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001567619-19-004398 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001567619-18-006318 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001567619-18-001107 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001140361-18-023974 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR/A 0001140361-18-009863 Quarter ended 2017-12-312018-02-23acceptance time not in the bulk data set
13F-HR 0001140361-18-008303 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001140361-17-042883 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001140361-17-032001 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001140361-17-020718 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001140361-17-007278 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001140361-16-086479 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001140361-16-076729 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001140361-16-065701 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001140361-16-053204 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR 0001140361-15-041780 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0001140361-15-032371 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001140361-15-019796 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001140361-15-006874 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0001140361-14-041694 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001140361-14-032743 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001140361-14-021259 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001140361-14-007193 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set